Myovant Sciences to Present New Data on Relugolix in Prostate Cancer at American Society of Clinical Oncology (ASCO) 2020 Annual Meeting

NEXT STORY
TRACON Pharmaceuticals Announces Presentation of Positive Clinical Data for Envafolimab in MSI-H/dMMR Cancer at ASCO 2020 Virtual Scientific Program by its Corporate Partners 3D Medicines and Alphamab
PREV STORY
Pluristem Provides 28-Day Follow Up for Ventilator-Dependent COVID-19 Patients under Compassionate Use Program in Israel and U.S.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results and Business Update

author_avatar
NASDAQ Market News

Active Biotech’s partner NeoTX to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

author_avatar
NASDAQ Market News

Reneo Pharmaceuticals Appoints Vineet R. Jindal as Chief Financial Officer

author_avatar
NASDAQ Market News